Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Regulus (RGLS) has issued an update.
Regulus Therapeutics Inc.’s stockholders made several key decisions at the Annual Meeting on May 16, 2024, including the election of ten directors and the ratification of Ernst & Young LLP as the independent auditor for the fiscal year. They also approved executive compensation and decided to hold annual advisory votes on the matter. Furthermore, an amendment to the 2019 Equity Incentive Plan was passed, increasing the authorized shares for issuance and adjusting the share reserve calculation. These decisions chart a clear course for the company’s governance and incentive structures in the coming year.
For a thorough assessment of RGLS stock, go to TipRanks’ Stock Analysis page.
